AMD on April 15 up to date its COVID-19 response technique to incorporate a large donation of enterprise {hardware} from its stock in the direction of COVID-19 vaccine analysis. The firm is gifting away $15 million price HPCs cloud computing nodes powered by EPYC enterprise processors and Radeon Instinct scalar compute accelerators to key analysis establishments on the forefront of vaccine analysis for COVID-19. AMD says that these methods shall be of a turnkey nature, in order that they may very well be rapidly deployed and put to make use of. The firm invitations any establishment conducting COVID-19 associated analysis to contact them for entry to the node.
Making the announcement, CEO Dr. Lisa Su writes: “AMD is announcing today a COVID-19 HPC fund to provide research institutions with computing resources to accelerate medical research on COVID-19 and other diseases. The fund will include an initial donation of $15 million of high-performance systems powered by AMD EPYC CPUs and AMD Radeon Instinct GPUs to key research institutions. To ease the implementation and speed the useful impact from these donations, we are working with our HPC system provider partners to provide ready-to-install HPC nodes. Research institutions should contact AMD at COVID-19HPC[at]amd[dot]com to submit proposals for access to these nodes.”
